机构:[1]Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Peoples R China[2]Wuhan Univ, Sch Basic Med Sci, Wuhan, Peoples R China[3]Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China[4]Wuhan Univ, Med Sci Res Ctr, Zhongnan Hosp, Wuhan, Peoples R China[5]Wuhan Univ, Dept Cardiol, Zhongnan Hosp, Wuhan, Peoples R China[6]Wuhan Univ, Dept Gastroenterol, Tongren Hosp, Wuhan, Peoples R China[7]Wuhan Third Hosp, Wuhan, Peoples R China[8]Cent South Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Peoples R China
Metabolic dysfunction is becoming a predominant risk for the development of many comorbidities. Ischemic heart disease (IHD) still imposes the highest disease burden among all cardiovascular diseases worldwide. However, the contributions of metabolic risk factors to IHD over time have not been fully characterized. Here, we analyzed the global disease burden of IHD and 15 associated general risk factors from 1990 to 2019 by applying the methodology framework of the Global Burden of Disease Study. We found that the global death cases due to IHD increased steadily during that time frame, while the mortality rate gradually declined. Notably, metabolic risk factors have become the leading driver of IHD, which also largely contributed to the majority of IHD-related deaths shifting from developed countries to developing countries. These findings suggest an urgent need to implement effective measures to control metabolic risk factors to prevent further increases in IHD-related deaths.
基金:
National Key R&D Program of China (2016YFF0101504 and 2020YFC2004702), the Special
Foundation for Emergency Research on Prevention and Control of COVID-
19 of Guangdong Province (2020B1111330003), the National Science Foundation
of China (81630011, 81970364, 81970070, 81970011, 81770053,
and 81870171), the Hubei Science and Technology Support Project
(2019BFC582 and 2018BEC473), and the Medical Flight Plan of Wuhan
University (TFJH2018006).
第一作者机构:[1]Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Peoples R China[3]Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Peoples R China[3]Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China[4]Wuhan Univ, Med Sci Res Ctr, Zhongnan Hosp, Wuhan, Peoples R China[8]Cent South Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Peoples R China
推荐引用方式(GB/T 7714):
Wang Wenxin,Hu Manli,Liu Hui,et al.Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease[J].CELL METABOLISM.2021,33(10):1943-+.doi:10.1016/j.cmet.2021.08.005.
APA:
Wang, Wenxin,Hu, Manli,Liu, Hui,Zhang, Xingyuan,Li, Haomiao...&Li, Hongliang.(2021).Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease.CELL METABOLISM,33,(10)
MLA:
Wang, Wenxin,et al."Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease".CELL METABOLISM 33..10(2021):1943-+